Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NV › Henderson › NPI 1134546575
Clinic

Urgent Care Nevada, LLC

Urgent Care Nevada, LLC was paid $34.81M by Medicaid between Jan 2018 and Dec 2024, across 45 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 45% of everything it billed.

33Billing provider infoURGENT CARE NEVADA, LLC
HENDERSON, NV 89052
33aNPI1134546575assigned 03/24/2014
28Total paid$34.81M
24GClaims662,473
24DCodes billed45
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Urgent Care Clinic/Center providers in Nevada

Rank by total paid#1 of 29
Median peer was paid$213K
This provider vs. median163×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official HOWORTH, WILLIAM controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201853,436$2.83M
201995,908$5.24M
202091,415$4.48M
2021109,740$5.91M
2022131,817$6.18M
2023112,967$5.84M
2024incomplete67,190$4.34M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 45% 208,174 179,746 $15.55M
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 17% 86,310 74,493 $6.08M
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 16% 58,921 51,788 $5.54M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 13% 69,234 61,928 $4.56M
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 2.6% 54,143 47,833 $910K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 1.9% 11,988 10,342 $661K
87428 1.2% 31,380 27,493 $433K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 10,956 9,856 $284K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 57,907 25,259 $256K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 44,815 39,274 $157K
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis <1% 791 758 $84K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 6,717 5,986 $81K
33 more codes
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 1,906 $57K
99205 Prolong outpt/office vis <1% 379 $48K
S9083 Global fee urgent care centers <1% 1,182 $22K
99201 <1% 354 $15K
71046 Radiologic examination, chest; 2 views <1% 909 $14K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,473 $13K
81025 <1% 2,836 $9K
73610 <1% 370 $7K
73630 <1% 400 $7K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 918 $4K
93000 <1% 315 $3K
73130 <1% 170 $3K
81003 <1% 2,188 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 914 $2K
73110 <1% 86 $2K
69209 <1% 195 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,436 $1K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 29 $805.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 130 $754.99
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 264 $657.54
73140 <1% 39 $597.58
73562 <1% 19 $299.00
A6449 Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard <1% 343 $257.16
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 588 $185.47
74018 <1% 20 $104.50
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 101 $33.35
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram <1% 14 $18.77
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram <1% 60 $12.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 16 $1.01
A9150 Non-prescription drugs <1% 257 $0.07
99051 0% 29 $0.00
99000 0% 3,181 $0.00
S8110 Peak expiratory flow rate (physician services) 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHOWORTH, WILLIAM (PRESIDENT, URGENT CARE)
Same official

Other billing entities under HOWORTH, WILLIAM

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.